Found: 16
Select item for more details and to access through your institution.
Clinicopathological, molecular, and prognostic features of colorectal carcinomas with KRAS c.34G>T (p.G12C) mutation.
- Published in:
- Cancer Science, 2024, v. 115, n. 10, p. 3455, doi. 10.1111/cas.16262
- By:
- Publication type:
- Article
Outcomes of esophageal bypass surgery and self-expanding metallic stent insertion in esophageal cancer: reevaluation of bypass surgery as an alternative treatment.
- Published in:
- Langenbeck's Archives of Surgery, 2020, v. 405, n. 8, p. 1111, doi. 10.1007/s00423-020-01969-x
- By:
- Publication type:
- Article
FA08.04: RELATIONSHIP BETWEEN PROGNOSTIC NUTRITIONAL INDEX AND PERITUMORAL IMMUNE SYSTEM DYNAMICS IN ESOPHAGEAL CANCER.
- Published in:
- Diseases of the Esophagus, 2018, v. 31, n. 13, p. 17, doi. 10.1093/dote/doy089.FA08.04
- By:
- Publication type:
- Article
PS02.216: PROPHYLAXIS OF POSTOPERATIVE VENOUS THROMBOEMBOLISM USING ENOXAPARIN AFTER ESOPHAGECTOMY: A PROSPECTIVE OBSERVATIONAL STUDY FOR EFFECTIVENESS AND SAFETY.
- Published in:
- Diseases of the Esophagus, 2018, v. 31, n. 13, p. 183, doi. 10.1093/dote/doy089.PS02.216
- By:
- Publication type:
- Article
Clinical significance of evaluating endoscopic response to neoadjuvant chemotherapy in esophageal squamous cell carcinoma.
- Published in:
- Digestive Endoscopy, 2020, v. 32, n. 1, p. 39, doi. 10.1111/den.13449
- By:
- Publication type:
- Article
Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 6, p. 1155, doi. 10.1038/s41416-022-02112-x
- By:
- Publication type:
- Article
Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Gut microbiome in gastrointestinal cancer: a friend or foe?
- Published in:
- International Journal of Biological Sciences, 2022, v. 18, n. 10, p. 4101, doi. 10.7150/ijbs.69331
- By:
- Publication type:
- Article
Inverse relationship between Fusobacterium nucleatum amount and tumor CD274 (PD‐L1) expression in colorectal carcinoma.
- Published in:
- Clinical & Translational Immunology, 2023, v. 12, n. 8, p. 1, doi. 10.1002/cti2.1453
- By:
- Publication type:
- Article
Adapted systemic inflammation score as a novel prognostic marker for esophageal squamous cell carcinoma patients.
- Published in:
- Annals of Gastroenterological Surgery, 2021, v. 5, n. 5, p. 669, doi. 10.1002/ags3.12464
- By:
- Publication type:
- Article
PD‐L1 and PD‐L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 2, p. 399, doi. 10.1111/cas.15198
- By:
- Publication type:
- Article
Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma.
- Published in:
- Cancer Science, 2020, v. 111, n. 9, p. 3132, doi. 10.1111/cas.14541
- By:
- Publication type:
- Article
Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 12, p. 3727, doi. 10.1111/cas.14214
- By:
- Publication type:
- Article
Indoleamine 2, 3‐dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 6, p. 1863, doi. 10.1111/cas.14028
- By:
- Publication type:
- Article
Prognostic role of inflammatory diets in colorectal cancer overall and in strata of tumor‐infiltrating lymphocyte levels.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 11, p. 1, doi. 10.1002/ctm2.1114
- By:
- Publication type:
- Article